AVIVA STRATEGIES (FKA MGB CONSULTING)

Lobbying for ACT FOR ULTRA RARE · Advocacy for ultra rare disease

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · $37,500.00 income · posted Apr 20, 2026

Lobbying activity 1

Health Issues

Ultra rare disease advocacy

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem